| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/12/23 | 8-K | Current report filing |
|
   |
3 |
| 05/10/23 | 8-K | Current report filing |
|
|
25 |
| 05/10/23 | 424B4 | Prospectus filed pursuant to Rule 424(b)(4) |
|
29 | |
| 05/10/23 | 8-K | Current report filing |
|
|
3 |
| 05/08/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/28/23 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
158 | |
| 04/14/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 04/03/23 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
35 | |
| 03/22/23 | DEF 14A | Definitive proxy statements |
|
57 | |
| 03/10/23 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
57 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.